FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Schlosser Michael J
(Last) (First) (Middle)
ONE PARK PLAZA
(Street)
NASHVILLE TN 37203
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/01/2026 		3. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and Chief Clinical Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 170.1027 (1)
D
 
Common Stock 6,951
I
By 2022 Trust
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right   (2) 02/01/2027 Common Stock 3,030 81.96 D  
Stock Appreciation Right   (3) 05/03/2027 Common Stock 1,898 82.85 D  
Stock Appreciation Right   (4) 01/31/2028 Common Stock 6,290 101.16 D  
Stock Appreciation Right   (5) 01/30/2029 Common Stock 4,400 139.06 D  
Stock Appreciation Right   (6) 01/29/2030 Common Stock 2,420 145.24 D  
Stock Appreciation Right   (7) 02/03/2031 Common Stock 2,100 173.12 D  
Stock Appreciation Right   (8) 07/22/2031 Common Stock 2,370 246.79 D  
Stock Appreciation Right   (9) 01/28/2032 Common Stock 4,160 236.61 D  
Stock Appreciation Right   (10) 01/30/2033 Common Stock 3,789 253.3 D  
Stock Appreciation Right   (11) 01/31/2034 Common Stock 3,577 304.9 D  
Stock Appreciation Right   (12) 01/28/2035 Common Stock 3,575 328.7 D  
Stock Appreciation Right   (13) 01/29/2036 Common Stock 3,103 482.53 D  
Explanation of Responses:
1. Includes 170.1027 shares acquired under the Issuer's employee stock purchase plans.
2. The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
3. The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018.
4. The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
5. The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.
6. The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.
7. The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.
8. The stock appreciation rights vested in four equal annual installments beginning on July 22, 2022.
9. The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023.
10. The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.
11. The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.
12. The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.
13. The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.
/s/ Kevin A. Ball, Attorney-in-Fact 09/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-24